CRASH2 logo
LSHTM logo
Worldwide research and postgraduate education in global health
Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage
A large randomised placebo controlled trial among trauma patients with, or at risk of, significant haemorrhage, of the effects of antifibrinolytic treatment on death and transfusion requirement
ISRCTN86750102
Click here to log into the Intranet
INTRANET FOR COLLABORATORS

Click here to fill in a form

To receive the trial results when they are published in 2010, you can register your interest here.

Peer reviewed Protocol is available on The Lancet protocol website »»» CLICK HERE

20,000 PATIENTS RANDOMISED

Congratulations to all our 274 collaborating hospitals in 40 countries for completing the randomisation of 20,000 patients!

Results will be available in the near future.

 

Last updated 11 February 2010